We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has released a public notification advising consumers not to purchase or use a weight loss and energy supplement called Natural Eruption. Read More
To shed light on the regulatory requirements for the development of co-crystals, the FDA is offering drugmakers submitting ANDAs and NDAs a clearer definition of co-crystals that no longer denotes them as an in-process material. Read More
Industry is praising the FDA for tackling both hiring and retention in its proposed goals for the next PDUFA, touting the proposals as necessary to support the agency’s initiatives. Read More
Gilead Sciences and Emory University have filed two lawsuits in U.S. District Court for the District of New Jersey against an India-based company over the patent rights to the HIV drug Truvada. One of the suits is related to two of the patents; another is related to all four patents. Read More